Trial intelligence / Profile preview

Dexmedetomidine vs Propofol Sedation for Sleep Endoscopy in Pediatric OSA

NCT05303987Phase 2Recruiting

Start
Oct 2022
Primary completion
Jan 2027
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of dexmedetomidine, propofol in obstructive sleep apnea (OSA). Started Oct 2022; status: recruiting.

02

Drugs

dexmedetomidinepropofol
03

Conditions

obstructive sleep apnea (OSA)

Beyond the preview

Go deeper on NCT05303987.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05303987.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call